View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. News
July 23, 2019updated 11 Aug 2019 4:25pm

NUCATS secures funds to improve patient participation in US

Northwestern University in the US has received a five-year grant from the National Institutes of Health (NIH) to support renewal of its Northwestern University Clinical and Translational Sciences (NUCATS) Institute.

The $46m funds will be leveraged by NUCATS to speed up clinical and translational discoveries in alliance with Northwestern investigators. The institute is expected to facilitate easy and safe clinical research participation.

NUCATS aims to expand research opportunities across the academic health system over the coming five years.

Through the Research Enabled and Accelerated in Community Healthcare (REACH) initiative, the institute will work to boost research in clinical care and improve patient participation in research studies or clinical trials.

NUCATS will also form alliances with two other National Center for Advancing Translational Sciences (NCATS)-funded hubs to create a new online solution for clinical enrolment.

Also, the institute will use the current Trial Innovation Network to link Northwestern investigators associated with multi-centre trials or studies with the clinical research consortium.

NUCATS director Donald Lloyd-Jones said: “This new Clinical and Translational Science Award will catalyse efforts to bring cutting-edge science and opportunities to participate in research studies to the point of care for doctors and patients across our growing health system and our community.

“We also will train the next generation of young scientists and study teams to answer the critical questions needed to improve human health.”

The institute will also use the fresh funds to further develop Northwestern’s clinical trials management system called enhance Study Tracker, in a bid to boost recruitment and efficiency.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU